Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study
dc.citation.issue | 11 | |
dc.citation.volume | 16 | |
dc.contributor.author | Lopez-Medrano, F. | |
dc.contributor.author | Fernandez-Ruiz, M. | |
dc.contributor.author | Silva, J. T. | |
dc.contributor.author | Carver, P. L. | |
dc.contributor.author | van Delden, C. | |
dc.contributor.author | Merino, E. | |
dc.contributor.author | Perez-Saez, M. J. | |
dc.contributor.author | Montero, M. | |
dc.contributor.author | Coussement, J. | |
dc.contributor.author | Mazzolin, Milene de Abreu [UNIFESP] | |
dc.contributor.author | Cervera, C. | |
dc.contributor.author | Santos, L. | |
dc.contributor.author | Sabe, N. | |
dc.contributor.author | Scemla, A. | |
dc.contributor.author | Cordero, E. | |
dc.contributor.author | Cruzado-Vega, L. | |
dc.contributor.author | Martin-Moreno, P. L. | |
dc.contributor.author | Len, O. | |
dc.contributor.author | Rudas, E. | |
dc.contributor.author | de Leon, A. P. | |
dc.contributor.author | Arriola, M. | |
dc.contributor.author | Lauzurica, R. | |
dc.contributor.author | David, M. | |
dc.contributor.author | Gonzalez-Rico, C. | |
dc.contributor.author | Henriquez-Palop, F. | |
dc.contributor.author | Fortun, J. | |
dc.contributor.author | Nucci, M. | |
dc.contributor.author | Manuel, O. | |
dc.contributor.author | Pano-Pardo, J. R. | |
dc.contributor.author | Montejo, M. | |
dc.contributor.author | Munoz, P. | |
dc.contributor.author | Sanchez-Sobrino, B. | |
dc.contributor.author | Mazuecos, A. | |
dc.contributor.author | Pascual, J. | |
dc.contributor.author | Horcajada, J. P. | |
dc.contributor.author | Lecompte, T. | |
dc.contributor.author | Moreno, A. | |
dc.contributor.author | Carratala, J. | |
dc.contributor.author | Blanes, M. | |
dc.contributor.author | Hernandez, D. | |
dc.contributor.author | Farinas, M. C. | |
dc.contributor.author | Andres, A. | |
dc.contributor.author | Aguado, J. M. | |
dc.coverage | Hoboken | |
dc.date.accessioned | 2020-07-31T12:47:26Z | |
dc.date.available | 2020-07-31T12:47:26Z | |
dc.date.issued | 2016 | |
dc.description.abstract | The prognostic factors and optimal therapy for invasive pulmonary aspergillosis (IPA) after kidney transplantation (KT) remain poorly studied. We included in this multinational retrospective study 112 recipients diagnosed with probable (75.0% of cases) or proven (25.0%) IPA between 2000 and 2013. The median interval from transplantation to diagnosis was 230 days. Cough, fever, and expectoration were the most common symptoms at presentation. Bilateral pulmonary involvement was observed in 63.6% of cases. Positivity rates for the galactomannan assay in serum and bronchoalveolar lavage samples were 61.3% and 57.1%, respectively. Aspergillus fumigatus was the most commonly identified species. Six- and 12-week survival rates were 68.8% and 60.7%, respectively, and 22.1% of survivors experienced graft loss. Occurrence of IPA within the first 6 months (hazard ratio [HR]: 2.29 | en |
dc.description.abstract | p-value = 0.027) and bilateral involvement at diagnosis (HR: 3.00 | en |
dc.description.abstract | pvalue = 0.017) were independent predictors for 6-week all-cause mortality, whereas the initial use of a voriconazole-based regimen showed a protective effect (HR: 0.34 | en |
dc.description.abstract | p-value = 0.007). The administration of antifungal combination therapy had no apparent impact on outcome. In conclusion, IPA entails a dismal prognosis among KT recipients. Maintaining a low clinical suspicion threshold is key to achieve a prompt diagnosis and to initiate voriconazole therapy. | en |
dc.description.affiliation | Univ Complutense, Sch Med, Dept Med,Hosp Octubre I 12 12, Unit Infect Dis,Hosp Univ Octubre 12,Inst Invest, Madrid, Spain | |
dc.description.affiliation | Univ Michigan Hlth Syst, Ann Arbor, MI USA | |
dc.description.affiliation | Univ Hosp Geneva, Dept Med Special, Infect Dis Serv, Geneva, Switzerland | |
dc.description.affiliation | Hosp Univ Gen, Infect Dis Unit, Alicante, Spain | |
dc.description.affiliation | Hosp del Mar, Med Res Inst, IMIM, Dept Nephrol, Barcelona, Spain | |
dc.description.affiliation | Hosp del Mar, Med Res Inst, IMIM, Dept Infect Dis, Barcelona, Spain | |
dc.description.affiliation | Univ Libre Bruxelles, Hop Erasme, Dept Nephrol Dialysis & Kidney Transplantat, Brussels, Belgium | |
dc.description.affiliation | Univ Fed Sao Paulo UNIFESP, Div Nephol, Dept Med, Sao Paulo, Brazil | |
dc.description.affiliation | Fundacao Oswaldo Ramos, Hosp Rim Hipertensao, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Barcelona, Sch Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Infect Dis,Hosp Clin, Barcelona, Spain | |
dc.description.affiliation | Coimbra Hosp & Univ Ctr, Dept Urol & Kidney Transplantat, Renal Transplantat Unit, Coimbra, Portugal | |
dc.description.affiliation | Hosp Univ Bellvitge, Dept Infect Dis, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain | |
dc.description.affiliation | Univ Paris 05, Hop Necker Enfants Malades, AP HP,RTRS Centaure, Serv Nephrol & Transplantat Adulte,Sorbonne Paris, Paris, France | |
dc.description.affiliation | Hosp Univ Vigen del Rocio, Infect Dis Unit, Inst Biomed Sevilla IBIS, Seville, Spain | |
dc.description.affiliation | Hosp Univ La Fe, Dept Nephrol, Valencia, Spain | |
dc.description.affiliation | Univ Navarra Clin, Dept Nephrol, Pamplona, Spain | |
dc.description.affiliation | Hosp Univ Vall dHebron, Vall dHebron Res Inst, Dept Infect Dis, Barcelona, Spain | |
dc.description.affiliation | Hosp Univ Carlos Haya, Dept Nephrol, Malaga, Spain | |
dc.description.affiliation | Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplantat, Mexico City, DF, Mexico | |
dc.description.affiliation | Clin Nefrol Urol & Enfermedades Cardiovasc, Santa Fe, Argentina | |
dc.description.affiliation | Univ Hosp Germans Trias & Pujol, Dept Nephrol, Barcelona, Spain | |
dc.description.affiliation | Univ Hosp Birmingham NHS Fdn Trust, Dept Microbiol, Birmingham, W Midlands, England | |
dc.description.affiliation | Univ Hosp Marques de Valdecilla, Dept Infect Dis, Santander, Spain | |
dc.description.affiliation | Univ Hosp Doctor Negrin, Dept Nephrol, Las Palmas Gran Canaria, Spain | |
dc.description.affiliation | Univ Hosp Ramon & Cajal, Dept Infect Dis, Madrid, Spain | |
dc.description.affiliation | Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Hematol Serv & Mycol Lab, Dept Internal Med, Rio De Janeiro, Brazil | |
dc.description.affiliation | Univ Hosp CHUV, Dept Infect Dis, Lausanne, Switzerland | |
dc.description.affiliation | Univ Hosp CHUV, Transplantat Ctr, Lausanne, Switzerland | |
dc.description.affiliation | Univ Lausanne, Lausanne, Switzerland | |
dc.description.affiliation | Univ Autonoma Madrid, Sch Med, Hosp Univ La Paz, Dept Internal Med, Madrid, Spain | |
dc.description.affiliation | Hosp Univ Cruces, Dept Infect Dis, Bilbao, Spain | |
dc.description.affiliation | Hosp Gen Univ Gregorio Maranon, Dept Microbiol & Infect Dis, Madrid, Spain | |
dc.description.affiliation | Univ Autonoma Madrid, Sch Med, Hosp Univ Puerta Hierro Majadahonda, Dept Nephrol, Madrid, Spain | |
dc.description.affiliation | Hosp Univ Puerta del Mar, Dept Nephrol, Cadiz, Spain | |
dc.description.affiliation | Hosp Univ La Fe, Infect Dis Unit, Valencia, Spain | |
dc.description.affiliation | Univ Complutense, Hosp Univ Octubre 12, Dept Nephrol, Inst Invest,Hosp Octubre I 12 12,Dept Med,Sch Med, Madrid, Spain | |
dc.description.affiliationUnifesp | Division of Nephrology, Department of Medicine, Universidade Federal de São Paulo‐UNIFESP, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Plan Nacional de I+D+i and Instituto de Salud Carlos III (Proyecto Integrado de Excelencia [PIE]) | |
dc.description.sponsorship | Subdireccion General de Redes y Centros de Investigacion Cooperativa, Spanish Ministry of Economy and Competitiveness, Spanish Network for Research in Infectious Diseases - European Development Regional Fund (EDRF) | |
dc.description.sponsorship | Pfizer Pharmaceutical | |
dc.description.sponsorship | Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness | |
dc.description.sponsorshipID | PIE: 13/00045 | |
dc.description.sponsorshipID | EDRF: REIPI RD12/0015 | |
dc.description.sponsorshipID | Pfizer Pharmaceutical: REI-ANT-2013-01 | |
dc.description.sponsorshipID | Instituto de Salud Carlos III: JR14/00036 | |
dc.format.extent | 3220-3234 | |
dc.identifier | http://dx.doi.org/10.1111/ajt.13837 | |
dc.identifier.citation | American Journal Of Transplantation. Hoboken, v. 16, n. 11, p. 3220-3234, 2016. | |
dc.identifier.doi | 10.1111/ajt.13837 | |
dc.identifier.issn | 1600-6135 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/56827 | |
dc.identifier.wos | WOS:000388204600021 | |
dc.language.iso | eng | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartof | American Journal Of Transplantation | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study | en |
dc.type | info:eu-repo/semantics/article |